Splenic Non-Hodgkin Lymphoma — Trials

Splenic Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

166 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 7
Ph III recruiting: 0
Growth YoY: —
Industry share: 12%
Top sponsor: City of Hope Medical Center
Termination share: 35.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (38)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07759661	Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination Therapies(IMPACT)	not yet recruiting	—	64	IRCCS San RaffaeleOTHER	1	Aug 13, 2026	clinicaltrials
NCT07638722	Testing Mosunetuzumab Alone, With Zanubrutinib, or With Polatuzumab Vedotin for Treating Marginal Zone Lymphoma That Came Back or Didn't Get Better With Treatment	not yet recruiting	Phase 2	138	SWOG Cancer Research NetworkNETWORK